Evolution of the Average Target: Ipsen

Evolution of the Target Price: Ipsen

Changes in Analyst Recommendations: Ipsen

5016d44bfcb8.izYLkeeQY0jNkg254tPUndzghtA4deAymnvHttLk5UI.0QM63bTqDWW44EiUtJKL3L6rw7hVAZp4oxGOz4Cgqg3KUDLT3uISCqLNRA~d55cd27d51f19a6833dccecc51b66855
14/07 Where would AI lead Pharma in the long run? Alphavalue
07/07 AlphaValue/Baader Europe Cuts Ipsen Price Target Amid Future Patent Expiries, Mid-term Risks MT
06/07 Ipsen: Reassessing mid-term risks Alphavalue
01/07 AlphaValue/Baader Europe Downgrades Ipsen to Add, Lifts PT MT
01/07 Oddo BHF still neutral on Ipsen after a new acquisition Zonebourse
30/06 Ipsen Extends Its Rally, Backed by Oddo BHF Zonebourse
05/06 HC Wainwright Starts Ipsen Coverage with Buy Rating MT
28/05 Ipsen Price Target, Estimates Up as AlphaValue/Baader Europe Notes Upcoming Data Readouts, Product Mix MT
27/05 Ipsen: Beneficiary of favourable product mix and imminent readouts Alphavalue
24/04 Profit-taking hits Ipsen despite UBS price target hike Zonebourse
24/04 Ipsen: Opened the year with encouraging traction Alphavalue
14/04 Deutsche Bank raises price target on Ipsen Zonebourse
16/03 BNP Paribas Upgrades Ipsen to Neutral, Boosts PT MT
10/03 CIC Corporate & Institutional Banking Upgrades Ipsen to Buy, Boosts PT MT
13/02 Ipsen Remains in the Green with UBS Support Zonebourse
12/02 Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook Alphavalue
14/01 Ipsen, Top Gainer on the SBF 120 and SRD at Wednesday, January 14, 2026 Close Zonebourse
14/01 Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle Zonebourse
08/01 UBS No Longer Recommends Buying Ipsen, Citing Full Valuation Zonebourse
26/11 BNP Paribas Downgrades Ipsen to Underperform, Trims PT MT
18/11 AlphaValue/Baader Europe Ups Ipsen's EPS Forecasts After Q3 Beat, 'Substantial' FY25 Outlook Upgrade MT
17/11 Ipsen raises 2025 outlook after stronger Somatuline Alphavalue
07/11 Ipsen to Present Positive Data on PBC at AASLD 2025 Zonebourse
22/25/22 Ipsen: Robust Q3 fuels a guidance upgrade Alphavalue
13/25/13 Ipsen: UBS reiterates buy recommendation Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.83%
+7.54%
+9.2%
+8.79%
+1.26%
+25.57%
-4.13%
-0.47%
+20.19%
Average +8.64%
Weighted average by Cap. +8.79%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
160.60EUR
Average target price
161.33EUR
Spread / Average Target
+0.46%
High Price Target
235.00EUR
Spread / Highest target
+46.33%
Low Price Target
117.00EUR
Spread / Lowest Target
-27.15%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Anas Patel
AlphaValue/Baader Europe
H.C. Wainwright
BNP Paribas
CIC Corporate & Institutional Banking
Sadif Investment Analytics
Deutsche Bank Securities
Kepler Cheuvreux
RBC Capital Markets
UBS
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
160.60EUR
Average target price
161.33EUR
Spread / Average Target
+0.46%

Quarterly revenue - Rate of surprise